Memphasys Limited (FRA:IG7)
Germany flag Germany · Delayed Price · Currency is EUR
0.0015
+0.0005 (50.00%)
At close: Dec 4, 2025

Memphasys Company Description

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes.

It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals.

In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation.

Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Memphasys Limited
Country Australia
Founded 2006
Industry Biological Products, Except Diagnostic Substances
Employees 24
CEO David Ali

Contact Details

Address:
34-36 Richmond Road
Homebush, New South Wales 2140
Australia
Phone 61 2 8415 7300
Website memphasys.com

Stock Details

Ticker Symbol IG7
Exchange Frankfurt Stock Exchange
Fiscal Year July - June
Reporting Currency AUD
SIC Code 2836

Key Executives

Name Position
David Ali Chief Executive Officer
Pablo Neyertz Chief Financial Officer
Hassan Bakos Chief Operating Officer